Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

This study tested a new drug called efsubaglutide alfa in 59 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. Participants received either a 3mg injection every two weeks or a 1mg injection weekly for 12 weeks. The goal was to see …